Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10316/112035
Título: | Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment | Autor: | Olloquequi, Jordi Ettcheto, Miren Cano, Amanda Fortuna, A. Bicker, Joana Sánchez-López, Elena Paz, Cristian Ureña, Jesús Verdaguer, Ester Auladell, Carme Camins, Antoni |
Palavras-chave: | neurodegeneration; cognitive enhancement; multi-target therapy | Data: | 16-Set-2023 | Editora: | MDPI | Título da revista, periódico, livro ou evento: | International Journal of Molecular Sciences | Volume: | 24 | Número: | 18 | Resumo: | Licochalcone A (Lico-A) is a flavonoid compound derived from the root of the Glycyrrhiza species, a plant commonly used in traditional Chinese medicine. While the Glycyrrhiza species has shown promise in treating various diseases such as cancer, obesity, and skin diseases due to its active compounds, the investigation of Licochalcone A's effects on the central nervous system and its potential application in Alzheimer's disease (AD) treatment have garnered significant interest. Studies have reported the neuroprotective effects of Lico-A, suggesting its potential as a multitarget compound. Lico-A acts as a PTP1B inhibitor, enhancing cognitive activity through the BDNF-TrkB pathway and exhibiting inhibitory effects on microglia activation, which enables mitigation of neuroinflammation. Moreover, Lico-A inhibits c-Jun N-terminal kinase 1, a key enzyme involved in tau phosphorylation, and modulates the brain insulin receptor, which plays a role in cognitive processes. Lico-A also acts as an acetylcholinesterase inhibitor, leading to increased levels of the neurotransmitter acetylcholine (Ach) in the brain. This mechanism enhances cognitive capacity in individuals with AD. Finally, Lico-A has shown the ability to reduce amyloid plaques, a hallmark of AD, and exhibits antioxidant properties by activating the nuclear factor erythroid 2-related factor 2 (Nrf2), a key regulator of antioxidant defense mechanisms. In the present review, we discuss the available findings analyzing the potential of Lico-A as a neuroprotective agent. Continued research on Lico-A holds promise for the development of novel treatments for cognitive disorders and neurodegenerative diseases, including AD. Further investigations into its multitarget action and elucidation of underlying mechanisms will contribute to our understanding of its therapeutic potential. | URI: | https://hdl.handle.net/10316/112035 | ISSN: | 1422-0067 | DOI: | 10.3390/ijms241814177 | Direitos: | openAccess |
Aparece nas coleções: | I&D CIBIT - Artigos em Revistas Internacionais FFUC- Artigos em Revistas Internacionais |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Licochalcone-A-A-Potential-Multitarget-Drug-for-Alzheimers-Disease-TreatmentInternational-Journal-of-Molecular-Sciences.pdf | 2.33 MB | Adobe PDF | Ver/Abrir |
Visualizações de página
83
Visto em 16/out/2024
Downloads
46
Visto em 16/out/2024
Google ScholarTM
Verificar
Altmetric
Altmetric
Este registo está protegido por Licença Creative Commons